Shufro Rose & Co’s Opko Health OPK Stock Holding History

Shufro Rose & Co’s Portfolio OPK Stock Details OPK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$25.5K	Hold	17,000	–	–	﹤0.01%	314
2026 Q1	$19.4K	Hold	17,000	–	–	﹤0.01%	307
2025 Q4	$21.4K	Hold	17,000	–	–	﹤0.01%	300
2025 Q3	$28.2K	Hold	17,000	–	–	﹤0.01%	315
2025 Q2	$28.2K	Hold	17,000	–	–	﹤0.01%	311
2025 Q1	$28.2K	Hold	17,000	–	–	﹤0.01%	313
2024 Q4	$25K	Hold	17,000	–	–	﹤0.01%	296
2024 Q3	$21.3K	Hold	17,000	–	–	﹤0.01%	313
2024 Q2	$21.3K	Hold	17,000	–	–	﹤0.01%	313
2024 Q1	$20.4K	Sell	17,000 -12,500	-42%	-$12.5K	﹤0.01%	314
2023 Q4	$47.2K	Hold	29,500	–	–	﹤0.01%	300
2023 Q3	$47.2K	Hold	29,500	–	–	﹤0.01%	302
2023 Q2	$64K	Sell	29,500 -8,100	-22%	-$12.7K	0.01%	305
2023 Q1	$54.9K	Hold	37,600	–	–	0.01%	310
2022 Q4	$47K	Buy	37,600 +14,000	+59%	+$22.1K	﹤0.01%	333
2022 Q3	$45K	Hold	23,600	–	–	﹤0.01%	324
2022 Q2	$60K	Sell	23,600 -1,000	-4%	-$2.92K	0.01%	307
2022 Q1	$85K	Buy	24,600 +2,100	+9%	+$7.42K	0.01%	318
2021 Q4	$108K	Hold	22,500	–	–	0.01%	295
2021 Q3	$82K	Hold	22,500	–	–	0.01%	287
2021 Q2	$91K	Hold	22,500	–	–	0.01%	285
2021 Q1	$97K	Hold	22,500	–	–	0.01%	286
2020 Q4	$89K	Sell	22,500 -6,000	-21%	-$25.1K	0.01%	272
2020 Q3	$105K	Sell	28,500 -29,200	-51%	-$123K	0.01%	263
2020 Q2	$197K	Hold	57,700	–	–	0.02%	244
2020 Q1	$77K	Sell	57,700 -7,600	-12%	-$11.9K	0.01%	270
2019 Q4	$96K	Sell	65,300 -10,700	-14%	-$17.9K	0.01%	298
2019 Q3	$159K	Sell	76,000 -6,000	-7%	-$12.3K	0.02%	283
2019 Q2	$200K	Sell	82,000 -39,300	-32%	-$85.7K	0.02%	268
2019 Q1	$317K	Sell	121,300 -46,800	-28%	-$142K	0.03%	208
2018 Q4	$506K	Sell	168,100 -49,600	-23%	-$168K	0.06%	158
2018 Q3	$753K	Buy	217,700 +7,500	+4%	+$39.8K	0.07%	145
2018 Q2	$988K	Buy	210,200 +11,300	+6%	+$42.9K	0.09%	122
2018 Q1	$631K	Buy	198,900 +12,900	+7%	+$51.9K	0.06%	150
2017 Q4	$911K	Buy	186,000 +23,500	+14%	+$136K	0.09%	128
2017 Q3	$1.11M	Sell	162,500 -31,200	-16%	-$197K	0.11%	116
2017 Q2	$1.27M	Buy	193,700 +2,000	+1%	+$14K	0.14%	98
2017 Q1	$1.53M	Sell	191,700 -1,300	-0.7%	-$10.9K	0.17%	94
2016 Q4	$1.79M	Buy	193,000 +16,500	+9%	+$171K	0.2%	85
2016 Q3	$1.87M	Buy	176,500 +27,800	+19%	+$277K	0.21%	82
2016 Q2	$1.39M	Buy	148,700 +19,000	+15%	+$193K	0.15%	97
2016 Q1	$1.35M	Hold	129,700	–	–	0.15%	98
2015 Q4	$1.3M	Buy	129,700 +43,300	+50%	+$434K	0.15%	99
2015 Q3	$726K	Sell	86,400 -3,800	-4%	-$50.3K	0.09%	133
2015 Q2	$1.45M	Buy	90,200 +2,500	+3%	+$38.9K	0.15%	95
2015 Q1	$1.24M	Sell	87,700 -2,300	-3%	-$29.9K	0.13%	104
2014 Q4	$899K	Hold	90,000	–	–	0.09%	128
2014 Q3	$765K	Hold	90,000	–	–	0.08%	134
2014 Q2	$795K	Buy	90,000 +32,900	+58%	+$287K	0.08%	134
2014 Q1	$532K	Buy	57,100 +5,500	+11%	+$48.2K	0.06%	162
2013 Q4	$435K	Buy	51,600 +28,800	+126%	+$291K	0.05%	173
2013 Q3	$200K	Sell	22,800 -5,700	-20%	-$45.7K	0.02%	223
2013 Q2	$202K	Buy	+28,500	New	+$197K	0.02%	225

Other funds holding OPK

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

WCM

Whitefort Capital Management New York $406M AUM 84.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Shufro Rose & Co's OPK Position: Q2 2026 in Review

Shufro Rose & Co held its Opko Health (OPK) position steady in Q2 2026 at 17,000 shares worth $25.5K. The position accounts for ﹤0.01% of the portfolio, ranked #314.

Shufro Rose & Co first reported a position in OPK in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.87M in Q3 2016. 223 funds tracked by Wall St. Rank hold OPK as of Q2 2026.

Shufro Rose & Co held 17,000 shares of Opko Health worth $25.5K as of Q2 2026.
Shufro Rose & Co left its Opko Health share count unchanged in Q2 2026.
Opko Health made up ﹤0.01% of Shufro Rose & Co's portfolio in Q2 2026, its #314 holding.
Shufro Rose & Co first reported a position in Opko Health in Q2 2013 and has held it in 53 quarters since.
Shufro Rose & Co's Opko Health position peaked at $1.87M in Q3 2016.
223 funds tracked by Wall St. Rank held Opko Health as of Q2 2026.

Based on Shufro Rose & Co's 13F filing for Q2 2026, filed 12 Aug 2026.